Search Results

GE HealthCare's Photonova Spectra Photon-Counting CT Receives CE Mark, to Be Commercialized in Countries Recognizing CE Marking

On August 31, GE HealthCare announced that its advanced photon-counting computed tomography (PCCT) system, Photonova Spectra, has received CE marking. The system utilizes GE HealthCare's proprietary Deep Silicon™ detector technology. This certification will expand the system's availability in countries and regions that recognize the CE mark and pave the way for its clinical use. According to reports, Photonova Spectra is designed to address the growing patient volumes and increasing diagnostic complexity faced by healthcare institutions today, aiming to provide clinicians with clearer and more timely imaging information. Leveraging deep silicon detector technology, the system can acquire spectral and spatial imaging information in each scan...

2026-09-01

Japan's Mihama Nuclear Power Station Unit 3 Plans Grid Connection on September 15

Kansai Electric Power announced on September 1, 2026, that work related to the periodic inspection of Unit 3 at Japan's Mihama Nuclear Power Station is progressing as planned. Based on the progress of the inspection and the status of corrective measures for the steam leakage issue in the high-pressure turbine, the unit is scheduled to be connected to the grid on September 15. Unit 3 of Mihama Nuclear Power Station is a pressurized water reactor unit with a rated electrical output of 826 MW and a rated thermal output of 2,440 MW. On May 8 this year, the unit underwent a manual reactor shutdown after steam leakage was confirmed in the high-pressure turbine. From June 16, the unit entered its 29th periodic inspection. Kansai Electric Power stated that, in response to the steam leakage in the high-pressure turbine, the upper cylinder sealing cover has been replaced based on the results of the cause investigation, and multiple measures such as the development of relevant guidelines are being advanced.

2026-09-01

Fourteen academic societies in South Korea call for protection of KRR-1 research reactor auxiliary buildings

On September 1, fourteen academic societies and associations, including the Korean Nuclear Society, issued a statement welcoming the temporary registration of the reactor hall and auxiliary buildings of Research Reactor Unit 1 (KRR-1, TRIGA Mark-II) in Gongneung-dong, Nowon-gu, Seoul, as nationally registered cultural heritage, and urged Korea Electric Power Corporation (KEPCO), the owner of the site and buildings, to promptly submit a formal registration application. Panoramic view of KRR-1, South Korea's first research reactor. Korea National Heritage Administration The Korea National Heritage Administration had placed the KRR-1 reactor hall and auxiliary buildings on the temporary list of nationally registered cultural heritage on July 1 through the emergency measures system, suspending related demolition work. However, if a formal registration application is not submitted by the end of December this year, the temporary listing will lapse and demolition work may resume.

2026-09-01

Dankook University Hospital Introduces Next-Generation Digital PET-CT System to Enhance Precision Diagnosis of Cancer and Other Diseases

Dankook University Hospital announced on September 1 that it has introduced GE HealthCare's next-generation digital PET-CT system, the OMNI Legend 32, to enhance precision diagnostic capabilities for a wide range of diseases, including cancer, brain disorders, and cardiac conditions. PET-CT is an important nuclear medicine diagnostic imaging modality. During the examination, a radiopharmaceutical is injected into the patient, and the system observes metabolic activity through positron emission tomography (PET) while simultaneously confirming anatomical structures via computed tomography (CT), thereby providing imaging evidence for clinical diagnosis. According to the hospital, the newly introduced OMNI Legend 32 employs AI-based image reconstruction technology to visualize small lesions with greater clarity, assisting physicians in making more accurate assessments...

2026-09-01

Kazakhstan Plans to Expand Researcher Participation in CERN High-Energy Physics Projects

Sayasat Nurbek, Acting Minister of Science and Higher Education of Kazakhstan, recently held talks with Mark Thomson, Director-General of the European Organization for Nuclear Research (CERN), during which the two sides exchanged views on deepening scientific and technological cooperation between Kazakhstan and CERN, with a focus on expanding cooperation in the field of high-energy physics and promoting researcher participation in CERN projects. According to the Ministry of Science and Higher Education of Kazakhstan, the Kazakh government and CERN signed an international cooperation agreement in 2018, laying the foundation for a long-term scientific research partnership between the two sides. At present, the two sides have drafted a supplementary protocol to the agreement, which plans to further specify the participation of Kazakh researchers in CERN...

2026-09-01

Beijing Jiluntai's ¹⁷⁷Lu-JLT003 Injection Receives IND Approval for Treatment of Integrin αvβ3-Positive Malignant Tumors

Beijing Jiluntai Pharmaceutical Co., Ltd. has recently achieved progress in radiopharmaceutical R&D. Its self-developed Class 1 innovative therapeutic radiopharmaceutical ¹⁷⁷Lu-JLT003 Injection (generic name: ¹⁷⁷Lu-AB-3PRGD2) has obtained the Clinical Trial Approval (IND) from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), intended for the treatment of integrin αvβ3-positive malignant tumors. ¹⁷⁷Lu-AB-3PRGD2 is a therapeutic radiopharmaceutical targeting integrin αvβ3. Integrin αvβ3 is highly expressed on various solid tumor cells and tumor neovascular endothelial cells, while showing low expression in normal tissues, a characteristic that...

2026-09-01

Sweden's Blykalla applies for government funding for advanced reactor park at Tierp

Untra Nuclear Power AB, a wholly owned project company of Swedish advanced nuclear energy firm Blykalla Group, submitted an application on August 31 seeking state support for investment in a new nuclear power plant. The project plans to build an advanced reactor park in the Untra area of Tierp municipality, Uppsala County, Sweden, with 6 to 8 SEALER-55 units planned. According to the project plan, if 8 units are built, the plant's total installed capacity would reach 440 MW, with an estimated annual generation of 3.68 TWh. Blykalla Group had previously submitted a government approval application for the project on August 25. Sweden's new nuclear financing model has...

2026-09-01

Russia's Leningrad Nuclear-Powered Icebreaker Electrical Distribution Equipment Passes Inspection

The Nuclear-Powered Vessels Division of the Russian Maritime Register of Shipping (RS) has recently completed an inspection of the new electrical distribution equipment for the Project 22220 universal nuclear-powered icebreaker Leningrad. The inspected equipment includes shore power distribution panels and low-voltage distribution panels, manufactured by Novaya ERA company of St. Petersburg. The Leningrad is currently under construction at the Baltic Shipyard, part of the United Shipbuilding Corporation (USC). The inspection was carried out by RS survey engineers upon the enterprise's application. The inspection results confirmed that the relevant equipment meets the requirements of current Russian regulations, and the manufacturer has been issued the corresponding registration certificates. The shore power distribution panel is used for...

2026-09-01

First Russia-IAEA Small Modular Reactor Training Course Concludes in Murmansk

On August 31, the Small Modular Reactor training course jointly organized by Rosatom Technical Academy and the International Atomic Energy Agency (IAEA) concluded in Murmansk, Russia. The training focused on operational experience and future prospects of small modular reactors. The five-day training brought together participants from Asia, Africa, the Middle East, and Latin America, including representatives from national nuclear energy agencies, regulatory bodies, and organizations interested in developing small nuclear power projects. Participants exchanged views on the current state of small modular reactor technology, readiness for engineering application, and deployment prospects. The course highlighted Russia's...

2026-09-01

Russian scientists use 3D-printed tungsten grid to improve X-ray imaging quality, potentially reducing patient radiation exposure

The press service of the Russian Ministry of Education and Science recently stated that a Russian research team has used 3D printing technology to manufacture a tungsten-based anti-scatter grid for X-ray machines, with partition thickness only one-third that of similar products. The researchers believe this achievement could help reduce patient radiation exposure during X-ray examinations while maintaining medical image quality. During X-ray imaging, some rays scatter after passing through human tissue, creating background noise that weakens image contrast. Clinical equipment typically suppresses such interference through anti-scatter grids. Traditional anti-scatter grids are mostly made of lead, but lead has low mechanical strength and imposes high requirements on processing techniques, resulting in...

2026-09-01

Bayer Presents Phase III Data for Iodine-124 PET Tracer: High Sensitivity Shown in Cardiac Amyloidosis Diagnosis

At the 2026 European Society of Cardiology Congress, Bayer presented results from the Phase III REVEAL study of its investigational PET radiotracer iodine-124 evuzamitide (I-124 evuzamitide). Data showed that the tracer met the study's primary endpoints in diagnostic sensitivity and specificity when used for imaging in patients with suspected cardiac amyloidosis. The REVEAL study, sponsored by Brigham and Women's Hospital, is a multicenter, open-label, single-arm Phase III clinical trial conducted at 18 sites in the United States, enrolling 170 adult patients with suspected cardiac amyloidosis. Following a single intravenous injection of I-124 evuzamitide, subjects underwent cardiac and...

2026-09-01

Defence Therapeutics Expands Radiopharmaceutical R&D Program to Evaluate Alpha and Beta Emitter Applications

MONTREAL, Quebec, Canada — Biotechnology company Defence Therapeutics Inc. recently announced the expansion of its radiopharmaceutical R&D program to include α and β radioisotopes in its evaluation scope, further validating the application potential of its proprietary Accum® technology in precision oncology. Defence Therapeutics is a publicly traded biotechnology company developing next-generation oncology treatments centered on its Accum® precision drug delivery platform. The company stated that the Accum® technology is designed to facilitate the entry of drug payloads into the intracellular compartment, thereby improving delivery efficiency. This expansion of the radiopharmaceutical program...

2026-09-01

CERN Accelerator Complex Enters Full LS3 Shutdown for Upgrades, Paving the Way for the High-Luminosity LHC Era

On the morning of August 31 local time, the injector complex and the Antimatter Factory at the European Organization for Nuclear Research (CERN) ceased operation after completing their final beam deliveries, officially entering the third Long Shutdown (LS3) phase. Earlier, the Large Hadron Collider (LHC) had been closed in June, marking the flagship accelerator as the first to kick off LS3 upgrade work at the center. Bettina Mikulec (left), head of the Operations Group at CERN, handed a symbolic baton—a miniature superconducting magnet from the LHC—to Jean-Philippe Tock (right), head of the LS3 Coordination Group, with CERN Director-General Mark Thomson (second from left) and Oliver Brüning (third from left), head of Accelerators and Technology, in attendance.

2026-09-01

Japan's Kyoto Fusioneering Secures Series D Funding Led by Korea-Japan Fusion Fund

IMM Investment Japan (IMMJ) announced on September 1 that it has led the Series D funding round for Kyoto Fusioneering, a Japanese fusion energy company. The investment was made through the Korea-Japan Fusion Fund, established jointly by Korean and Japanese investors. The fund, initiated by IMMJ, is positioned as a cross-border project fund designed to connect the capital and industrial networks of major Korean corporations with Japan's cutting-edge technology companies. Investors participating in the fund include POSCO Holdings, POSCO International, Doosan, Hyundai Motor, and GS...

2026-09-01

Tennessee Issues First-Ever Commercial Fusion-Specific Permit in the U.S. to Type One Energy

The Tennessee Department of Environment and Conservation (TDEC) has issued Type One Energy the state's first permit specifically for a fusion energy facility, allowing the company to advance fusion-related projects at the Tennessee Valley Authority's (TVA) Bull Run Energy Complex in Clinton. Tennessee officials stated this is the first permit of its kind in the United States issued under a new state-level fusion regulatory framework. Tennessee Governor Bill Lee, alongside fusion energy partners, presented the first U.S. permit specifically for a commercial fusion facility on Monday at the Organization of American States (OAS) annual meeting in Nashville. (LR) TVA Interim...

2026-09-01